Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

SHE/300238 stock hub

SHE/300238 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SHE/300238is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

3.8B

Shenzhen Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

SHE/300238

In the news

Latest news · SHE/300238

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 17.1P50 24.2P75 37.8

Trailing P/E198.6

P25 23.5P50 41.3P75 83.2

ROE1.5

P25 -0.9P50 4.1P75 8.8

ROIC1.9

P25 -0.5P50 5P75 11.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SHE/300238 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

220

Groups with data

Currency

CNY

Showing 220 of 220 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	CN
Employees	535
Employees Change	5%
Employees Change Percent	0.94
Enterprise value	CNY 3.7B
Exchange	Shenzhen Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Biotechnology
Isin	CNE100001575
Last refreshed	2026-05-10
Market cap	CNY 3.8B
Price	CNY 14.34
Price currency	CNY
Rev Per Employee	722,236.75x
Sector	Healthcare
Sic	3842
Symbol	she/300238
Website	https://www.guanhaobio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	0.52%
EV Earnings	188.5x
EV/EBIT	168.7x
EV/EBITDA	78.36x
EV/FCF	223.78x
EV/Sales	9.58x
FCF yield	0.44%
P/B ratio	7.68x
P/E ratio	198.64x
P/S ratio	9.84x
PE Ratio10 Y	125.71x
PE Ratio3 Y	145.66x
PE Ratio5 Y	123.51x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	5.93%
EBITDA Margin	11.25%
FCF margin	4.28%
Gross margin	76.54%
Gross Profit	CNY 295.8M
Gross Profit Growth	-1.52%
Gross Profit Growth Q	-1.95%
Gross Profit Growth3 Y	11.7%
Gross Profit Growth5 Y	-2.97%
Net Income	CNY 19.6M
Net Income Growth	-29.58%
Net Income Growth Q	-31.64%
Net Income Growth Years	0%
Net Income Growth5 Y	-18.1%
Pretax Margin	4.84%
Profit Margin	5.08%
Profit Per Employee	CNY 36,714
Profitable Years	3
ROA	1.85
Roa5y	1.82
ROCE	3.62
ROE	1.48
Roe5y	-7.44
ROIC	1.91
Roic5y	2.15

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-9.47%
Cagr1y	8.48%
Cagr3y	4.08%
Cagr5y	-6.62%
Div CAGR10	-4.59%
EPS Growth	-31.63
EPS Growth Q	-33.33
EPS Growth Years	0
EPS Growth5 Y	-19.35
FCF Growth3 Y	17.11%
FCF Growth5 Y	-35.22%
OCF Growth	-20.79%
OCF Growth10 Y	-2.79%
OCF Growth3 Y	-8.07%
OCF Growth5 Y	-22.27%
Revenue Growth	1.46x
Revenue Growth Q	-1.43x
Revenue Growth Years	1x
Revenue Growth3 Y	1.73x
Revenue Growth5 Y	-3.93x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CNY 0.5
Assets	CNY 787.2M
Cash	CNY 144.2M
Current Assets	CNY 307.8M
Current Liabilities	CNY 153.6M
Debt	CNY 129.6M
Debt EBITDA	CNY 2.69
Debt Equity	CNY 0.26
Debt FCF	CNY 7.83
Equity	CNY 494.9M
Interest Coverage	5.79
Liabilities	CNY 292.3M
Long Term Assets	CNY 479.4M
Long Term Liabilities	CNY 138.7M
Net Cash	CNY 14.6M
Net Cash By Market Cap	CNY 0.38
Net Debt EBITDA	CNY -0.34
Net Debt Equity	CNY -0.03
Net Debt FCF	CNY -0.88
Tangible Book Value	CNY 509.5M
Tangible Book Value Per Share	CNY 2.01
WACC	5.72

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2
Inventory Turnover	1.25
Net Working Capital	CNY 25M
Quick ratio	1.35
Working Capital	CNY 154.2M
Working Capital Turnover	CNY 2.66

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-3%
Dividend per share	CNY 0
Last Dividend	CNY 0.05
Payout Ratio	18.25%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-63.02%
1Y total return	8.47%
200-day SMA	15.84
3Y total return	12.74%
50-day SMA	15.24
50-day SMA vs 200-day SMA	50under200
5Y total return	-29.01%
All Time High	63.1
All Time High Change	-77.27%
All Time High Date	2015-06-12
All Time Low	6.52
All Time Low Change	120.11%
All Time Low Date	2012-12-03
ATR	0.48
Beta	0.29
Beta1y	0.31
Beta2y	0.72
Ch YTD	3.54
High	14.4
High52	19.98
High52 Date	2025-08-01
High52ch	-28.23%
Low	14.21
Low52	13.02
Low52 Date	2025-05-22
Low52ch	10.14%
Ma50ch	-5.87%
Price vs 200-day SMA	-9.49%
RSI	41.91
RSI Monthly	50.29
RSI Weekly	43.06
Sharpe ratio	0.43x
Sortino ratio	0.94
Total Return	-3%
Tr YTD	3.54
Tr1m	-7.9%
Tr1w	0.63%
Tr3m	-7.96%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CNY 22.9M
Operating Income Growth	-32.05
Operating Income Growth Q	-39.18
Operating Income Growth5 Y	-12.14
Operating margin	5.93

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	199,786,173%
Net Borrowing	5,264,872
Shares Insiders	1.87%
Shares Institutions	6.94%
Shares Out	265,155,701
Shares Qo Q	-9.42%
Shares Yo Y	3%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CNY 16.5M
Average Volume	5,205,091.65x
Bv Per Share	2.28
CAPEX	CNY -26M
Ch10y	-63.23
Ch1m	-7.9
Ch1w	0.63
Ch1y	8.47
Ch3m	-7.96
Ch3y	12.74
Ch5y	-29.01
Ch6m	-4.84
Change	0.42%
Change From Open	0.91
Close	14.28
Days Gap	-0.49
Depreciation Amortization	20,531,133
Dollar Volume	57,514,872
Earnings Date	2026-04-29
EBIT	CNY 22.9M
EBITDA	CNY 43.5M
EPS	CNY 0.07
F Score	5
FCF	CNY 16.5M
FCF EV Yield	0.45x
FCF Per Share	CNY 0.06
Financing CF	1,787,171
Fiscal Year End	December
Founded	1,999
Graham Number	1.92586
Graham Upside	-86.57
Income Tax	CNY 11.4M
Investing CF	-21,600,446
Is Primary Listing	1
Last Earnings Date	2026-04-29
Last Report Date	2026-03-31
Last Split Date	2015-04-16
Last Split Type	Forward
Lynch Fair Value	CNY 0.36
Lynch Upside	-97.48
Ma150	15.45
Ma150ch	-7.19%
Ma20	14.86
Ma20ch	-3.49%
Net CF	22,366,920
Next Earnings Date	2026-08-26
Open	14.21
P FCF Ratio	229.8
P OCF Ratio	89.3
Position In Range	68.42
Ppne	331,947,870
Price Date	2026-05-08
Price EBITDA	CNY 87.51
Ptbv Ratio	7.46
Relative Volume	0.8x
Revenue	386,396,659x
Tax By Revenue	2.96x
Tax Rate	61.14%
Tr6m	-4.84%
Volume	4,010,800

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does SHE/300238 pay a dividend?

Capital-return profile for this ticker.

Performance

SHE/300238 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SHE/300238?

Insider, institutional, and short-interest positioning.

Institutional ownership

+6.9%

Share of float held by funds and institutions

Insider ownership

+1.9%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+3.0%

Negative means the company is buying back shares.

Technical

SHE/300238 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

41.9

Neutral momentum band

Price vs 200-day MA

-9.5%

50/200-day relationship not available

Beta (5Y)

0.29

Less volatile than the market

Sharpe ratio

0.43

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SHE/300238

Hub-level FAQ points readers to the deeper analysis pages.

What is the current she/300238 stock rating?

she/300238 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full she/300238 analysis?

The full report lives at /stocks/she/300238/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for she/300238?

The latest report frames she/300238 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the she/300238 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.